Pancreatic Cancer Research

ResearcherShandong UniversityActive in the last 2 years

Tonggang Qi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6358-8786; OpenAlex author ID A5068379239, A5149285088. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
4
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. TXNL1 Knockout Suppresses Pancreatic Cancer Cell Proliferation, Invasion, and EMT via Concomitant Inhibition of MEK/ERK and PI3K/AKT Signaling Last author DOI 10.21203/rs.3.rs-10693416/v1↗
  2. Multi-omic characterization of MAP4 in pancreatic adenocarcinoma progression: epitranscriptomic networks, EMT Activation, and stromal-immune dynamics Last author DOI 10.21203/rs.3.rs-6702603/v1↗
  3. Homoharringtonine could induce quick protein synthesis of PSMD11 through activating MEK1/ERK1/2 signaling pathway in pancreatic cancer cells. Co-author DOI 10.1002/jcb.26847↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jin Yan¹ · 1 shared paper, 2026 · strength 0.43
  2. Longyan Zuo · 1 shared paper, 2025 · strength 0.30
  3. Chuanxin Wang · 1 shared paper, 2018 · strength 0.09
  4. Dieter Saur · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.